An open, randomized, controlled trial of penicillin, doxycycline, and cefotaxime for patients with severe leptospirosis

Clinical Infectious Diseases

Volumn 39, Issue 10, 2004, Pages 1417-1424

  Suputtamongkol, Yupin ^a   Niwattayakul, Kanigar ^c   Suttinont, Chuanpit ^d   Losuwanaluk, Kitti ^e   Limpaiboon, Roongroeng ^f   Chierakul, Wirongrong ^b   Wuthiekanun, Vanaporn ^b   Triengrim, Surapee ^a   Chenchittikul, Mongkol ^g   White, Nicholas J ^b,h  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c Muang Loei Ram Hospital   (Thailand)

^d MAHARAT NAKHON RATCHASIMA HOSPITAL   (Thailand)

^e Banmai Chaiyapod Hospital   (Thailand)

^f Udonthani Hospital   (Thailand)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

^h CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; DOXYCYCLINE; GENTAMICIN; PENICILLIN G;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GRAM NEGATIVE SEPSIS; HUMAN; LEPTOSPIROSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; OPEN STUDY; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RICKETTSIOSIS; THAILAND; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CEFOTAXIME; DOXYCYCLINE; FEMALE; HUMANS; LEPTOSPIROSIS; MALE; MIDDLE AGED; PENICILLINS; SEVERITY OF ILLNESS INDEX;

EID: 8744284697     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/425001     Document Type: Article

References (24)

1. Bharti AR, Nally JE, Ricaldi JN, et al. Leptospirosis: a zoonotic disease of global concern. Lancet Infect Dis 2003; 3:757-71.
2. Yersin C, Bovet P, Merien F, et al. Pulmonary hemorrhage as a predominant cause of death in leptospirosis in Seychelles. Trans R Soc Trop Med Hyg 2000; 94:71-6.
3. Zaki SR, Shieh W-J. Leptospirosis associated with outbreak of acute febrile illness and pulmonary haemorrhage, Nicaragua, 1995. The Epidemic Working Group at Ministry of Public Health in Nicaragua. Lancet 1996; 347:535.
4. Choomkasien P. Leptospirosis. In: Wattanasri S, ed. Summary of disease surveillance report 1998, Division of Epidemiology, Office of Permanent Secretary, Ministry of Public Health, Bangkok. Bangkok: Veteran Organization Press, 1999:205-13.
5. Bovet P, Yersin C, Merien F, Davis CE, Perolat P. Factors associated with clinical leptospirosis: a population-based case-control study in the Seychelles (Indian Ocean). Int J Epidemiol 1999; 28:583-90.
6. Ashford DA, Kaiser RM, Spiegel RA, et al. Asymptomatic infection and risk factors for leptospirosis in Nicaragua. Am J Trop Med Hyg 2000; 63:249-54.
7. Daher E, Zanetta DMT, Cavalcante MB, Abdulkader RC. Risk factors for death and changing patterns in leptospirosis acute renal failure. Am J Trop Med Hyg 1999; 61:630-4.
8. Alexander AD, Rule PL. Penicillins, cephalosporins, and tetracyclines in treatment of hamsters with fatal leptospirosis. Antimicrob Agent Chemother 1986; 30:835-9.
9. Watt G, Padre LP, Tuazon ML, et al. Placebo-controlled trial of intravenous penicillin for severe and late leptospirosis. Lancet 1988; 1:433-5.
10. Edwards CN, Nicholson GD, Hassell TA, Everard CO, Callender J. Penicillin therapy in icteric leptospirosis. Am J Trop Med Hyg 1988; 39:338-90.
11. Daher E, Nogueira CB. Evaluation of penicillin therapy in patients with leptospirosis and acute renal failure. Rev Inst Med Trop Sao Paulo 2000; 42:327-32.
12. Costa E, Lopes AA, Sacramento E, et al. Penicillin at the late stage of leptospirosis: a randomized controlled trial. Rev Inst Med Trop Sao Paulo 2003; 45:141-5.
13. Panaphut T, Domrongkitchaiporn S, Vibhagool A, Thinkamrop B, Susaengrat W. Ceftriaxone compared with sodium penicillin G for treatment of severe leptospirosis. Clin Infect Dis 2003; 36:1507-13.
14. Vinetz JM. A mountain out of a molehill: do we treat acute leptospirosis, and if so, with what? Clin Infect Dis 2003; 36:1514-5.
15. Hospenthal DR, Murray CK. In vitro susceptibilities of seven Leptospira species to traditional and newer antibiotics. Antimicrob Agents Chemother 2003; 47:2646-8.
16. McClain JB, Ballou WR, Harrison SM, Steinweg DL. Doxycycline therapy for leptospirosis. Ann Intern Med 1984; 100:696-8.
17. Takafuji ET, Kirkpatrick JW, Miller RN, et al. An efficacy trial of doxycycline chemoprophylaxis against leptospirosis. N Engl J Med 1984; 10:497-500.
18. Appassakij H, Silpapojakul K, Wansit R, Woodtayakorn J. Evaluation of the immunofluorescent antibody test for the diagnosis of human leptospirosis. Am J Trop Med Hyg 1995; 52:340-3.
19. Pradutkanchana S, Pradutkanchana J, Khuntikij P. Detection of IgM specific antibody using indirect immunofluorescent assay for diagnosis of acute leptospirosis. J Med Assoc Thai 2003; 86:641-6.
20. Suputtamongkol Y, Sarawish S, Silpasakon S, Potha U, Silpapojakul K, Naigowit P. Microcapsule agglutination test for the diagnosis of leptospirosis in Thailand. Ann Trop Med Parasitol 1998; 92:797-801.
21. Robinson DM, Brown G, Gan E, Huxsoll DL. Adaptation of a microimmunofluorescence test to the study of human Rickettsia tsutsugamushi antibody. Am J Trop Med Hyg 1976; 25:900-5.
22. La Scola B, Raoult D. Laboratory diagnosis of rickettsioses: current approaches to diagnosis of old and new rickettsial diseases. J Clin Microbiol 1997; 35:2715-27.
23. World Health Organization (WHO). Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. 2nd ed. Geneva: WHO, 1997.
24. Watt G, Jongsakul K, Suttinont C. Possible scrub typhus coinfections in Thai agricultural workers hospitalized with leptospirosis. Am J Trop Med Hyg 2003; 68:89-91.